Navigation Links
Big Pharma already has a generic strategy, but needs new direction


In his February 14, 2005 article, Michael Rosen argues that Big Pharma "will be forced into generic-drug strategy," and suggests that this will be a good thing. But Big Pharma already has a generic drug strategy for traditional pharmaceuticals. This strategy has not been particularly good for anyone,......

Full article >>> nd become subject to generic competition.

Blockbuster drugs have provided valuable therapies ranging from non-sedating antihistamines, cancer treatments, pain relief and, yes, even erectile dysfunction. But the number of conditions that could give rise to a blockbuster drug is limited. Countless medical conditions exist that lack adequate treatment or would benefit from improved treatment......

Full article >>> can and should be done to encourage healthier eating and exercising among the American population. With a healthier population, there will be less need for drugs to treat for conditions such as obesity-induced diabetes. More resources should then be available to develop drugs for other conditions such as cancer and macular degeneration.

The bottom line is that we do not need Big Pharma t......

Full article >>>
'"/>

Source:wistechnology.com By Steven F. Weinstock and Patricia J. Kaeding 03/16/05


Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
4. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
5. Deltanoid Pharmaceuticals begins phase II osteoporosis study
6. The deconstruction of Big Pharma
7. First half of 2006 roundup: Big Pharma trumps biotech
8. Big Pharmas continued hunger and search for new products
9. Leading global Big Pharma companies of 2005
10. Theres more than a bit of mystery, but attracting Big Pharma is good for the state
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
(Date:2/23/2017)... ... 2017 , ... Today, researchers can fast-track sample collection and ... other biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the ... between insulin and other relevant biomarkers can be extensively studied through a non-invasive ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
(Date:2/22/2017)... CINCINNATI , Feb. 22, 2017 Scientists ... drives inflammation and organ damage in Gaucher and maybe ... fewer risks and lower costs than current therapies. ... Children,s Hospital Medical Center , which also included investigators ... , report their data Feb. 22. The study ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):